Events Partner Content CAR-T Congress USA | 20 - 22 March 2018 | Boston Targeting | Commercialization | Scalability
Events Partner Content Immuno-Oncology 360° Summit Immuno-Oncology 360° is a comprehensive program providing exposure to the entire spectrum of R&D, addressing key aspects from all facets of IO including:
News Immunocore hires Lilly's Hotchkiss as chief commercial offic... UK biotech leading in the nascent field of TCR immunotherapy has appointed Andrew Hotchkiss as its new Chief Commercial Officer.
News BMS and Infinity aim to overcome triple negative breast canc... BMS is looking to get ahead of its rival Merck & Co. by overcoming resistance to PD-1 immunotherapy in triple negative breast cancer patients.
Views & Analysis Interview: AZ's immunotherapy gamble starts to pay off Robert Iannone, AstraZeneca's head of immune-oncology research, on the unpredictable immunotherapy market.
News BMS and Roche look to Halozyme drug delivery for IO advantag... Bristol-Myers Squibb is to work with drug delivery specialist Halozyme to create an injectable form of its blockbuster immunotherapy Opdivo.
News ADARx, Trex, and Retension take aim at IPOs The appetite among biotechs for IPOs shows no signs of being satisfied, with three more – ADARx, TRex, and Retension – making their intentions known.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
